2019年1期
刊物介紹
Cancer Biology & Medicine is a peer-reviewed open-access journal of Chinese Anti-cancer Association (CACA), which is the leading professional society of oncology in China. The journal quarterly provides innovative and significant information on biological basis of cancer, cancer microenvironment, translational cancer research, and all aspects of clinical cancer research. The journal also publishes significant perspectives on indigenous cancer types in China. The scope covers the following topics: ● Cancer epigenetics ● Cancer stem cell ● Improved in vivo and in vitro cancer models ● Cancer prevention and epidemiology ● Biomarkers for predicting drug response ● Mechanism of drug sensitivity and resistance ● New approaches for cancer detection and diagnosis ● Oncology clinical trials ● Targeted therapy ● Multidisciplinary treatment for cancer Author benefits: ● Easy online submission via Editorial Manager ● Efficient and professional peer-review by expert referees from around the world ● Rapid pre-print online publication ● No charge for publication and Open Access ● International visibility - the journal is available free online
Cancer Biology & Medicine
- The breakthrough in primary human hepatocytes in vitro expansion
- Next-generation sequencing and its clinical application
- Circular RNAs and human glioma
- Qidong: a crucible for studies on liver cancer etiology and prevention
- The PI3K/Akt/GSK-3β/ROS/eIF2B pathway promotes breast cancer growth and metastasis via suppression of NK cell cytotoxicity and tumor cell susceptibility
- Estrogen and insulin synergistically promote endometrial cancer progression via crosstalk between their receptor signaling pathways
- Simultaneous inhibition of PI3Kα and CDK4/6 synergistically suppresses KRAS-mutated non-small cell lung cancer
- p53 mutation regulates PKD genes and results in co-occurrence of PKD and tumorigenesis
- STIM1 overexpression in hypoxia microenvironment contributes to pancreatic carcinoma progression
- Memory stem T cells generated by Wnt signaling from blood of human renal clear cell carcinoma patients
- Risk factors for cervical lymph node metastasis in papillary thyroid microcarcinoma: a study of 1,587 patients
- BRAFV600E vs. TIRADS in predicting papillary thyroid cancers in Bethesda system I, III, and V nodules
- Clinicopathologic and molecular characteristics of 44 patients with pure secretory breast carcinoma
- Identification of portal vein tumor thrombus with an independent clonal origin in hepatocellular carcinoma via multi-omics data analysis
- 68Gallium-labelled PSMA-PET/CT as a diagnostic and clinical decision-making tool in Asian prostate cancer patients following prostatectomy
- Perioperative rh-endostatin with chemotherapy improves the survival of conventional osteosarcoma patients: a prospective non-randomized controlled study
- Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-1210
- Methods of computed tomography screening and management of lung cancer in Tianjin: design of a population-based cohort study
- Application of next-generation sequencing technology to precision medicine in cancer: joint consensus of the Tumor Biomarker Committee of the Chinese Society of Clinical Oncology
- Periostin mediates epithelial-mesenchymal transition through the MAPK/ERK pathway in hepatoblastoma